
I have moved over to Threads @seantunis
Baltimore / Zoom
Joined April 2011
- Tweets396
- Following508
- Followers886
- Likes271
Sean Tunis retweeted
Attending #ISPOR2024? Check out our panel on FDA advisory committees - this Sun, 5/5, 5:30-6:30, Rm A411, Congress Center
- Joseph Daval, JD, @PORTAL_Research
- @SeanTunis, MD, Rubix Health
- me @USCPrice @SchaefferCenter
Moderator: @CostAnEffect (David Howard) @EmoryRollins
Sean Tunis retweeted
My new @NEJM Perspective with @SeanTunis:
@CMSGov is becoming a major #HTA organization.
It should embrace the role.
tinyurl.com/3f56499a
@TuftsCEVR @TuftsMedicalCtr @Arnold_Ventures @HTAiOrg @UW_Pharmacy @SchaefferCenter @DusetzinaS #heor @a_kaltenboeck @joeymattingly
Sean Tunis retweeted
The new @CMSGov registry for #Alzheimer's drugs is a start, but seems unlikely to answer key clinical outcomes questions any time soon -- even with links to #Medicare claims data. (Subscription required)
tinyurl.com/ympkpzek @SeanTunis @TuftsCEVR #Leqembi
Hey all - I am going over the Thread and will be deleting my twitter account. Hope to find many of you again over there.
1
254
Sean Tunis retweeted
Capacity-enhancing innovations enable access to innovative care while reducing burdens on healthcare providers and hospitals ➡ Recognizing this value, measuring, and rewarding it, requires adaptive HTA methods to inform policy makers’ decisions.
We are sponsoring the “Value Creation And Efficiency Gains Through #CapacityEnhancing #Innovations To Address Workforce Shortage” symposium at the #HTAi2023Adelaide.
More on: htai.eventsair.com/htai-23-a…
#HTAi2023 @HTAiOrg
Sean Tunis retweeted
“#HTA is most robust around things that can be parameterized and measured.
You can measure things like workforce satisfaction, utilization of staff, etc.
HTA will be most helpful at broadening the range of parameters to measure technologies that are #CapacityEnhancing.” Adds Dr. @SeanTunis
#HTAi2023Adelaide @HTAiOrg
Sean Tunis retweeted
Doctors are worried that #AI and robotic technology will replace them. Can #HTA protect the doctor-patient relationship? @dollendorf @bliden @SeanTunis #HTAi2023Adelaide
Sean Tunis retweeted
What do @CMSGov's latest statements on coverage of #Alzheimers therapies mean for future evidence generation and patient access?
@SeanTunis and I unpack the issues @Health_Affairs. tinyurl.com/h2aw6jrc #rwe @TuftsCEVR
Sean Tunis retweeted
Let us introduce you to the expert panel at the “Value Creation And Efficiency Gains Through #CapacityEnhancing #Innovations To Address Workforce Shortage” symposium.
🎤 Mr. Seth Clancy
🎤 Ms. @Tanyamareehall
🎤 Pr. Danny Liew
🎤 Dr. Wija @OortwijnW
🎤 Dr. Laura @ColomSampietro
🎤 Dr. @SeanTunis
#HTAi2023Adelaide #HTAi2023 @HTAiOrg
Sean Tunis retweeted
Déjà vu? Here's an excerpt from FDA CBER Director's decision memo on his rationale for accelerated approval of Sarepta's Elevidys, where he discusses why he overrode his own medical reviewers who did not find clear efficacy evidence for 4-5 year olds. fda.gov/media/169707/downloa…
Sean Tunis retweeted
- When will data collection infrastructure be ready?
- How will data on benefits/risks be collected?
- How will data be entered & by whom?
- What impact on patient access?
- How much will this cost & who pays?
- Will it show opportunities for a “learning health care system”?
2/2
Sean Tunis retweeted
In @Health_Affairs Forefront today, @SeanTunis & I explore key questions for #Medicare’s real-world data collection strategy for new #Alzheimers therapies.
tinyurl.com/h2aw6jrc @TuftsCEVR #RWE @TheADDF @alzassociation @ISPORorg @HTAiOrg @alzforum
1/2
Sean Tunis retweeted
In their new Forefront article, @SeanTunis + @PeterNeumann11 of @TuftsCEVR discuss the FDA's upcoming decision regarding approval for Leqembi (lecanemab), a monoclonal antibody for patients with mild cognitive impairment or mild Alzheimer’s disease. bit.ly/448tzUz
Sean Tunis retweeted
Made it to the interactive @WithingsFR exhibit in Paris today! Props to the team for a great event showing off what these technologies can do and the difference they can make in people’s lives. So glad we could make it!
Sean Tunis retweeted
This panel on streamlining FDA and CMS processes was a great way to wrap up #isporannual. Panelists touched on accelerated approval, CED, lessons learned from #alzheimers mabs, and more. @PeterNeumann11 @SeanTunis @a_kaltenboeck
Sean Tunis retweeted
My first publication at @TuftsCEVR leveraging SPEC data. Coverage of #Makena unlikely to change until FDA withdraws the drug; leaving the drug on the market furthers health plan inaction. @PeterNeumann11 @jchambers241 healthaffairs.org/do/10.1377…
Sean Tunis retweeted
One word: RANDOMIZE 👇🏻👇🏻
Just out @TheLancet
Failure of Molnupiravir to reduce Covid hospitalizations or deaths in a very large randomized trial (N>25,000 participants, mean age 57, 99% vaccinated) thelancet.com/journals/lance…
Sean Tunis retweeted
Here is ChatGPT auto-writing a letter of medical necessity for liquid biopsy for a patient with metastatic breast cancer. References and all!
Sean Tunis retweeted
‘Core Outcome Measures in Effectiveness Trials (COMET) Initiative’ at @LivUni, which has provided a public database of outcomes for clinical trials making it easier for researchers to find which outcomes are recommended as measures @COMETInitiative (original COMET members📷🔽)
Sean Tunis retweeted
A new rejoinder from @caseybmulligan and @tomasphilipson argues that the IRA will indeed undermine Medicare Part D. TLDR: They still misunderstand what the law does and, thus, reach the same erroneous conclusions.
wsj.com/articles/medicare-be…

























